Navigation Links
Quest PharmaTech's Prostate Cancer Program Update

sily confirmed by fluorescence detection. PDT treatment of the prostate gland causes complete glandular tissue ablation within the intact capsule. Sexual and urological functions appear to be intact after the treatment with some acute voiding difficulties observed within the first few days.

Based on the exciting pre-clinical results, Quest will be compiling a pre-IND package, including chemical and manufacturing, toxicology, pharmacology and clinical protocol, and seek a pre-IND meeting with regulatory authorities as we progress this technology towards human clinical trials.

"We are very excited about the treatment results, and its potential as a first line therapy for prostate cancer. This warrants further testing of this new technology in a clinical setting," said Dr. Ron Moore, Professor of Surgery and Oncology, Faculty of Medicine, University of Alberta and Cross Cancer Institute.

SL052 for the treatment of prostate cancer is being developed in collaborations with Dr. Ron Moore and Dr. Jimmy Xiao of the Alberta Cancer Board, Dr. John Tulip at the Faculty of Engineering, University of Alberta and Dr. Dwayne Dickey, with support from the Alberta Ingenuity Fund and the National Research Council Canada, Industrial Research Assistance Program (NRC-IRAP).

The Company's lead photodynamic therapy product, SL017, is a topical formulation indicated for dermatology applications. The utility of SL017 has already been demonstrated for hair removal applications in a Phase I clinical trial. In Jan 2007, the Company initiated a fifty patient pivotal clinical trial for the same indications. In addition, SL017 is currently undergoing a Canadian Phase I clinical trial for Actinic Keratosis.

About Quest PharmaTech Inc.

The Corporation is a publicly traded , Alberta-based drug development company committed to the development and commercialization of new pharmaceutical products. It is developing a series of products for the treatment of cance
'"/>




Page: 1 2 3

Related medicine technology :

1. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
2. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
3. To Stent or Not: Is That the Question?
4. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
7. Molecular Insight Pharmaceuticals, Inc. Presents Preclinical Data on Molecular Imaging Pharmaceutical for Prostate Cancer
8. Poniard Pharmaceuticals Announces Promising Data From Interim Safety Analysis of Phase 1 Combination Trials of Picoplatin in Colorectal and Prostate Cancers
9. Vakzine Projekt Management Reports Positive Clinical Trial Results With Their Therapeutic Prostate Cancer Vaccine VPM4001
10. Algeta to Present Phase II Clinical Study Data for Alpharadin in Prostate Cancer at ASCO
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Quest PharmaTech Prostate Cancer Program Update
(Date:12/2/2009)... 2 Hospira, Inc. (NYSE: ...n and medication delivery technologies, announced ...eraDoc, a clinical informatics company that develo...eading products, Infection Control Assistant(TM) a...ing portfolio of medication safety and infection m...
(Date:12/2/2009)...nia, December 2 Shire,pl...y biopharmaceutical,company, announces that it has...USA, Inc. ("Teva") over Shire,s supply to Teva of ...e has been supplying Teva with,authorized generic ...o supply,the product had been limited by restricti...
(Date:12/2/2009)...ire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (... and Drug Administration (FDA) has granted Fast Tr...pany,s novel, potentially first-in-class, oral ant...3-kinase (PI3K)/Akt pathway, for the treatment of ...Fast Track program of the FDA is designed to facil...
Breaking Medicine Technology:Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 4Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 5Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4Catalyst Pharmaceutical Partners Inc Announces the Closing of 243 97 Million Registered Direct Offering 5278 1Catalyst Pharmaceutical Partners Inc Announces the Closing of 243 97 Million Registered Direct Offering 5278 2Officials Stress Safety as Swine Flu Vaccine Arrives 59005 1Officials Stress Safety as Swine Flu Vaccine Arrives 59005 2Officials Stress Safety as Swine Flu Vaccine Arrives 59005 3Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinsons Disease 59000 1Henry Ford West Bloomfield Hospital Launches Gene Therapy Study for Parkinsons Disease 59000 2
... Nov. 3 Mpex Pharmaceuticals, Inc. today,announce...ith MP-376 for,use as a maintenance therapy in red...patients with chronic obstructive pulmonary diseas...n of levofloxacin,inhalation solution., The Phase...cebo-controlled study (Mpex 302) is expected to en...
...percent of patients achieve undetectable viral loa...eatment with standard of care, SAN FRANCISCO, Nov...TMC435, an investigational protease inhibitor (PI)... of chronic hepatitis C virus,(HCV) infection. Tib...es,including a late-breaker poster on the proof-of...
Other Medicine Technology:Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD 2Mpex Pharmaceuticals Announces Initiation of a Phase 2 Clinical Trial of Aerosol MP-376 in COPD 3Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 2Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 3Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 4Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008 5
(Date:12/2/2009)... A team of Kendall Hunt authors earned the 2... at the recent National Association for Gifted Chi...mber 5-7, 2009. , Dubuque... Hunt authors earned the 2009 Gifted Child Quarter...Association for Gifted Children’s annual con...
(Date:12/2/2009)... Today,s Washington Post Highlights Dangers ...-- If the Catholic bishops have their way, many...ake for granted may be under threat. The pressure...ebate over healthcare reform has been widely repor...ns of the likely impact if that pressure to influe...
(Date:12/2/2009)...uspected in birth defect that affects male urethra...(HealthDay News) -- Male babies of women who use i...pregnancy appear to be at increased risk for a bir..., This birth defect, which affects about two of...ning of the urethra, the tube that carries urine f...
(Date:12/2/2009)... seem like unlikely heroes in the battle against d...sects already used to study dozens of human disea...g that fruit flies can be used as a simpler and mo...s of cocaine and other drugs of abuse on the brain...oscience , a new monthly journal. , Andrew Ewin...
(Date:12/2/2009)... MyCareTeam, Inc., a leading vendor of Inter... released the newest version of its software offer...ongestive heart failure and weight management capa...toring features. , Acto...., a leading vendor of Internet-based chronic dise...
Breaking Medicine News(10 mins):Health News:Kendall Hunt Authors Earn NAGC “Paper of the Year” Award 2Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2
...are shedding light on a rare form of early blindne...way for possible therapies// to treat or even prev...The findings, funded by Fight for Sight and the Na...nce his post-doctoral days at Harvard University, ...
...o your pizza or spaghetti, make sure it’s made fro... Scientists from Ohio State University have report...nown antioxidant found in tomatoes, is absorbed be.... Lycopene is said to be a potent antioxidan...
...racic cancer, reportedly the countries number one ...ed// to have specialist comprising of radiation on...estigators. These experts are flying in from Unite...c cancers from around the globe. Several papers wi...
...rican women found that most of them had insufficie...nd physical health// , personal lives, professiona...rvey sponsored by the National Sleep Foundation, s...p each week, and 40 percent have disturbed sleep e...
...ch researchers suggest that the hormone glucocorti... be//. The steroid is prescribed by many specialis... The steroid hormones called glucocorticoids...o sensitize the lining of the uterus so that embry...
...sity finds that women on the Atkins low-carbohydra...ar diets//. It also found that their blood pressur... On average, women taking the Atkins diet lost 1... those following the Zone weight-loss plan. ...
Other Medicine News:Health News:Biologists Trace Cause Of Early Blindness To Tissue Defect 2Health News:Biologists Trace Cause Of Early Blindness To Tissue Defect 3Health News:Pass the Orange Tomato Sauce Please 2Health News:Sleep Problems of Women 2Health News:Atkin’s Low-carb Diet Best for Weight Los 2
Gigli (Olivecrona) Wire Saws
Galt Skull Trephine
Cone Skull Punch
Greenberg Pattie Tray
Medicine Products: